Gene Therapy for Leber Congenital Amaurosis in Mice
Author Information
Author(s): Alexis-Pierre Bemelmans, Corinne Kostic, Sylvain V. Crippa, William W. Hauswirth, Janis Lem, Francis L. Munier, Mathias W. Seeliger, Andreas Wenzel, Yvan Arsenijevic
Primary Institution: Jules Gonin Eye Hospital, Lausanne, Switzerland
Hypothesis
Can lentiviral gene transfer of Rpe65 prevent cone degeneration and restore cone function in Rpe65 knockout mice?
Conclusion
Lentiviral gene transfer of Rpe65 protects and restores cone function in Rpe65 knockout mice, suggesting a potential treatment for RPE65 deficiencies.
Supporting Evidence
- Gene transfer restored retinal function to a near-normal pattern.
- Rpe65 gene transfer completely prevented cone degeneration for at least four months.
- The study established an algorithm for predicting cone-rescue area based on transgene expression.
Takeaway
Scientists used a special virus to deliver a gene to mice that helps their eyes work better, which could help people with a type of blindness.
Methodology
Mice received subretinal injections of a lentiviral vector expressing Rpe65, followed by electroretinogram recordings and histological analyses.
Limitations
The study was conducted in mice, and further research is needed to determine the safety and efficacy in humans.
Participant Demographics
Rpe65 knockout mice
Statistical Information
P-Value
0.023
Statistical Significance
p=0.023
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website